S047 Up-to-date Treatment of Hair, Scalp and Nail Disorders
DESCRIPTION
This session is aimed to provide a very practical guide for the treatment of hair, scalp and nail disorders. It will discuss approved and off-label treatments for common and uncommon types of alopecia, for scalp inflammation and itching and for common nail disorders. The session will discuss indications and efficacy of hair and nail procedures including intra-lesional injections. It will also provide recommendations for treating and managing hair and nail disorders in patients of different ethnicities and genders, including transgender patients . Although focused to educate the younger audience, it will provide an up-to-date review for all providers.
LEARNING OBJECTIVES
Select best treatment for the patients with different types of alopecia
Select best treatment for patients with scalp inflammation/itching
Select best treatment for patients with nail disorders
SCHEDULE
1:00 PM
Introduction
Antonella Tosti, MD, Brian William Morrison, MD, MSc, FAAD
1:05 PM
Simple diagnostic tools for diagnosis of nail disorders
Dimitris Rigopoulos, MD, IFAAD
1:11 PM
What’s new in the treatment of nail psoriasis
Matilde Iorizzo, PhD, MD, IFAAD
1:17 PM
Monodactylous longitudinal nail plate changes :differential diagnosis and work-up
Brian William Morrison, MD, MSc, FAAD
1:24 PM
Dermatophytoma
Shari Lipner, MD, PhD, FAAD
1:30 PM
What’s new in the treatment of nail lichen planus
Bianca Maria Piraccini, MD, IFAAD
1:36 PM
Glomus tumor, diagnosis and treatment
Soumiya Chiheb
1:43 PM
Questions and answers
Antonella Tosti, MD, Soumiya Chiheb, Matilde Iorizzo, PhD, MD, IFAAD, Shari Lipner, MD, PhD, FAAD, Brian William Morrison, MD, MSc, FAAD, Bianca Maria Piraccini, MD, IFAAD, Dimitris Rigopoulos, MD, IFAAD
1:53 PM
Treating alopecia areata in 2024
Maryanne Makredes Senna, MD, FAAD
2:00 PM
Traction Alopecia with Religious Headcovering
May El Samahy, MD
2:07 PM
Update on oral minoxidil
Antonella Tosti, MD
2:14 PM
Intralesional treatments for hair loss
Rodrigo Pirmez, MD
2:20 PM
Hair oils : good or bad?
Boni E. Elewski, MD, FAAD
2:27 PM
Treating hair loss in women with cancer
Fernanda Torres, MD
2:33 PM
Haircare recommendation for women of African descent
Yolanda M Lenzy, MD, FAAD
2:40 PM
questions and answers
Antonella Tosti, MD, May El Samahy, MD, Boni E. Elewski, MD, FAAD, Yolanda M Lenzy, MD, FAAD, Maryanne Makredes Senna, MD, FAAD, Brian William Morrison, MD, MSc, FAAD, Rodrigo Pirmez, MD, Fernanda Torres, MD
2:50 PM
Treatment of Central Centrifugal Cicatricial Alopecia
Amy J McMichael, MD, FAAD
2:57 PM
Good & Wrong Candidates for Hair Transplants
Andrei Doroshkevich, MD, IFAAD
3:04 PM
Traction alopecia
Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD
3:11 PM
Treating of hair loss in transgender patients
Daniel Asz-Sigall, MD, IFAAD
3:18 PM
What’s new in the treatment of Frontal Fibrosing Alopecia
Sergio Vano-Galvan, MD, PhD, IFAAD
3:25 PM
What's new on antiandrogens
Maria Abril Martinez Velasco, MD
3:32 PM
My surgical tips
Martin N. Zaiac, MD, FAAD
3:39 PM
Questions and answers
Antonella Tosti, MD, Daniel Asz-Sigall, MD, IFAAD, Andrei Doroshkevich, MD, IFAAD, Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD, Amy J McMichael, MD, FAAD, Brian William Morrison, MD, MSc, FAAD, Sergio Vano-Galvan, MD, PhD, IFAAD, Martin N. Zaiac, MD, FAAD
DIRECTOR
Antonella Tosti, MD
SPEAKERS
Daniel Asz-Sigall, MD, IFAAD
Soumiya Chiheb
Andrei Doroshkevich, MD, IFAAD
May El Samahy, MD
Boni E. Elewski, MD, FAAD
Matilde Iorizzo, PhD, MD, IFAAD
Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD
Yolanda M Lenzy, MD, FAAD
Shari Lipner, MD, PhD, FAAD
Maryanne Makredes Senna, MD, FAAD
Maria Abril Martinez Velasco, MD
Amy J McMichael, MD, FAAD
Brian William Morrison, MD, MSc, FAAD
Bianca Maria Piraccini, MD, IFAAD
Rodrigo Pirmez, MD
Dimitris Rigopoulos, MD, IFAAD
Fernanda Torres, MD
Sergio Vano-Galvan, MD, PhD, IFAAD
Martin N. Zaiac, MD, FAAD
HANDOUTS
DISCLOSURES
Daniel Asz-Sigall, MD, IFAAD
No financial relationships exist with ineligible companies.
Soumiya Chiheb
No financial relationships exist with ineligible companies.
Andrei Doroshkevich, MD, IFAAD
No financial relationships exist with ineligible companies.
May El Samahy, MD
No financial relationships exist with ineligible companies.
Boni E. Elewski, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);
Matilde Iorizzo, PhD, MD, IFAAD
AbbVie – Investigator(Fees); Almirall – Speaker(Fees); Johnson and Johnson – Advisory Board(Fees); Laboratoires Bailleul – Advisory Board(Fees); Leo Pharma – Advisory Board(Fees); Springer Publishing – Other(Other Financial Benefit); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD
No financial relationships exist with ineligible companies.
Yolanda M Lenzy, MD, FAAD
CeraVe/Valeante – Other(Fees); Neutrogena – Consultant (1099 relationship)(Grants/Research Funding);
Shari Lipner, MD, PhD, FAAD
Veradermics – Advisory Board(Honoraria);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);
Maria Abril Martinez Velasco, MD
No financial relationships exist with ineligible companies.
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Brian William Morrison, MD, MSc, FAAD
No financial relationships exist with ineligible companies.
Bianca Maria Piraccini, MD, IFAAD
Difa Cooper – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Fees); Giuliani Pharma – Consultant (1099 relationship)(Honoraria); L'Oréal France – Advisory Board(Fees); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Dimitris Rigopoulos, MD, IFAAD
No financial relationships exist with ineligible companies.
Fernanda Torres, MD
No financial relationships exist with ineligible companies.
Antonella Tosti, MD
Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);
Sergio Vano-Galvan, MD, PhD, IFAAD
AbbVie – Speaker(Fees); Cantabria Labs – Advisory Board(Fees); Fotofinder – Speaker(Fees); L'Oréal France – Advisory Board(Fees); Lilly ICOS LLC – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Fees);
Martin N. Zaiac, MD, FAAD
No financial relationships exist with ineligible companies.